Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China flag China · Delayed Price · Currency is CNY
21.95
+0.29 (1.34%)
Jul 29, 2026, 4:00 PM EDT

SHA:603207 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
541.9525.28474.58471.87456.89401.77
Revenue Growth
13.19%10.68%0.57%3.28%13.72%11.22%
Gross Profit
345.56341.25311.3308.8269.45254.43
Operating Income
235.35238.19233.49230.48195.85142.84
Net Income
203.65207.49205.27203.63175.18126.27
Earnings Per Share
1.271.291.531.701.461.05
EPS Growth
-13.58%-15.69%-10.00%16.44%39.05%-

Revenue by Geography

Fiscal YearFY 2025
Period EndingDec '25
East China
182.77
North China
69.59
South China
85.52
Southwest
59.12
Central China
58.87
Northeast
45.23
Northwest
23.4
Overseas
0.21
Total
524.7

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
646.48647.59883.43288.52168.93208.01
Total Debt
7.72.52.320.860.881.27
Net Cash (Debt)
638.78645.08881.11287.65168.05206.74
Net Cash Growth
-30.00%-26.79%206.31%71.17%-18.71%83.45%
Net Cash Per Share
3.984.016.572.401.401.72

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
152.91160.8212.21200.26137.2179.51
Capital Expenditures
-82.29-54.24-83.94-80.15-61.59-12.48
Free Cash Flow
70.62106.56128.27120.1175.61167.03
Free Cash Flow Growth
-35.50%-16.93%6.79%58.86%-54.73%20.59%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.77%64.96%65.59%65.44%58.97%63.33%
Operating Margin
43.43%45.35%49.20%48.84%42.86%35.55%
Pretax Margin
43.71%45.92%50.47%50.26%45.10%38.47%
Profit Margin
37.58%39.50%43.25%43.15%38.34%31.43%
FCF Margin
13.03%20.29%27.03%25.45%16.55%41.57%

Dividends

Fiscal YearCurrentFY 2025FY 2024
Period EndingJul '26 Dec '25 Dec '24
Dividend Per Share
1.0701.0701.500
Dividend Per Share Growth
0%-28.67%-
Dividend Yield
4.94%3.80%5.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.2922.1521.90---
P/FCF Ratio
49.9843.1335.04---
PS Ratio
6.518.759.47---